SYFce6840b7081545e98963b1c913098b4aRegistry ID: 2024-517547-31-00|RecruitingPhase 1
Loading search results
interventional
N/A
3 countries
5
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 16, 2024
Actual (reported)Centre hospitalier universitaire de Liege
Liege, 4000, Belgium
SGS Belgium
Edegem, 2650, Belgium
Fraunhofer Institute For Translational Medicine And Pharmacology ITMP
Frankfurt Am Main, 60596, Germany
Universitaetsklinikum Erlangen AöR
Erlangen, 91054, Germany
Director Clinical Operations
First Submitted
December 16, 2024
Download the complete CTIS (EMA) record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: European Medicines Agency (EMA), Clinical Trials Information System (CTIS). Original record and public documents are available on CTIS.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
A Study in Healthy Adults and Adult Subjects With Rheumatoid Arthritis to Evaluate the Safety, Tolerability and Pharmacokinetics After Multiple Doses of ABT-494
Centre for Human Drug Research
Leiden, 2333 CL, Netherlands